Konjac glucomannan reverses multi-drug resistance of HepG2/5-FU cells by suppressing AKT signaling and increasing p53 expression.Published in:Oncology Letters, 2020, v. 20, n. 3, p. 2105, doi. 10.3892/ol.2020.11790By:Chen, Bin;Xu, Xin;Zheng, Ke;Liu, Ling;Yu, Yijun;Xin, YingPublication type:Article